• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predicting Treatment-seeking Status for Alcohol Use Disorder Using Polygenic Scores and Machine Learning in a Deeply-Phenotyped Sample.在一个深度表型样本中使用多基因评分和机器学习预测酒精使用障碍的治疗寻求状态
medRxiv. 2024 Nov 23:2024.11.22.24317810. doi: 10.1101/2024.11.22.24317810.
2
Predicting treatment-seeking status for alcohol use disorder using polygenic scores and machine learning in a deeply-phenotyped sample.在一个深度表型样本中,使用多基因评分和机器学习预测酒精使用障碍的治疗寻求状态。
Drug Alcohol Depend. 2025 Sep 1;274:112797. doi: 10.1016/j.drugalcdep.2025.112797. Epub 2025 Jul 16.
3
Alcohol Use Disorder Polygenic Score Compared With Family History and ADH1B.酒精使用障碍多基因评分与家族史及乙醇脱氢酶1B的比较。
JAMA Netw Open. 2024 Dec 2;7(12):e2452705. doi: 10.1001/jamanetworkopen.2024.52705.
4
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.创伤后应激障碍及共病物质使用障碍的心理治疗
Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2.
5
Application of polygenic scores to a deeply phenotyped sample enriched for substance use disorders reveals extensive pleiotropy with psychiatric and somatic traits.多基因评分在深度表型化的物质使用障碍富集样本中的应用揭示了与精神和躯体特征广泛的多效性。
Neuropsychopharmacology. 2024 Dec;49(13):1958-1967. doi: 10.1038/s41386-024-01922-2. Epub 2024 Jul 23.
6
Pharmacotherapy for anxiety and comorbid alcohol use disorders.焦虑症合并酒精使用障碍的药物治疗
Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD007505. doi: 10.1002/14651858.CD007505.pub2.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Pharmacological treatments in panic disorder in adults: a network meta-analysis.成人惊恐障碍的药物治疗:网络荟萃分析。
Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3.
9
Psychosocial interventions for cannabis use disorder.针对大麻使用障碍的心理社会干预措施。
Cochrane Database Syst Rev. 2016 May 5;2016(5):CD005336. doi: 10.1002/14651858.CD005336.pub4.
10
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

在一个深度表型样本中使用多基因评分和机器学习预测酒精使用障碍的治疗寻求状态

Predicting Treatment-seeking Status for Alcohol Use Disorder Using Polygenic Scores and Machine Learning in a Deeply-Phenotyped Sample.

作者信息

Jinwala Zeal, Green ReJoyce, Khan Yousef, Gelernter Joel, Kember Rachel L, Hartwell Emily E

出版信息

medRxiv. 2024 Nov 23:2024.11.22.24317810. doi: 10.1101/2024.11.22.24317810.

DOI:10.1101/2024.11.22.24317810
PMID:39606347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11601739/
Abstract

BACKGROUND

Few individuals with alcohol use disorder (AUD) receive treatment. Previous studies have shown drinking behavior, psychological problems, and substance dependence to predict treatment seeking. However, to date, no studies have incorporated polygenic scores (PGS), a measure of genetic risk for AUD.

METHODS

Using the Yale-Penn sample, we identified 9,103 individuals diagnosed with DSM-IV AUD and indicated treatment-seeking status. We implemented a random forest (RF) model to predict treatment-seeking based on 91 clinically relevant phenotypes. We calculated AUD PGS for those with genetic data (African ancestry [AFR] n=3,192, European ancestry [EUR] n=3,553) and generated RF models for each ancestry group, first without and then with PGS. Lastly, we developed models stratified by age (< and ≥40 years old).

RESULTS

66.6% reported treatment seeking (M =40.0, 62.4% male). Across models, top predictors included years of alcohol use and related psychological problems, psychiatric diagnoses, and heart disease. In the models without PGS, we found 79.8% accuracy and 0.85 AUC for EUR and 75% and 0.78 for AFR; the addition of PGS did not substantially change these metrics. PGS was the 10 most important predictor for EUR and 23 for AFR. In the age-stratified analysis, PGS ranked 8 for <40 and 48 for ≥40 in EUR ancestry, and it ranked 14 for <40 and 24 for ≥40 in the AFR sample.

CONCLUSION

Alcohol use, psychiatric issues, and comorbid medical disorders were predictors of treatment seeking. Incorporating PGS did not substantially alter performance, but was a more important predictor in younger individuals with AUD.

HIGHLIGHTS

While alcohol use problems are common, few individuals seek treatmentWe used machine learning in a deeply-phenotyped sample to predict treatment-seekingWe, for the first time, incorporated polygenic risk for alcohol use as a predictorAlcohol use variables, psychiatric issues, and medical problems were key predictors.

摘要

背景

很少有酒精使用障碍(AUD)患者接受治疗。先前的研究表明,饮酒行为、心理问题和物质依赖可预测寻求治疗的情况。然而,迄今为止,尚无研究纳入多基因评分(PGS),这是一种衡量AUD遗传风险的指标。

方法

利用耶鲁-宾夕法尼亚样本,我们确定了9103名被诊断为DSM-IV AUD并表明寻求治疗状态的个体。我们实施了一个随机森林(RF)模型,以基于91种临床相关表型预测寻求治疗的情况。我们为有基因数据的个体(非洲血统[AFR] n = 3192,欧洲血统[EUR] n = 3553)计算了AUD PGS,并为每个血统组生成了RF模型,首先不使用PGS,然后使用PGS。最后,我们开发了按年龄分层(<40岁和≥40岁)的模型。

结果

66.6%的人报告寻求治疗(平均年龄 = 40.0岁,62.4%为男性)。在所有模型中,最重要的预测因素包括饮酒年限和相关心理问题、精神疾病诊断以及心脏病。在不使用PGS的模型中,我们发现欧洲血统组的准确率为79.8%,曲线下面积(AUC)为0.85;非洲血统组的准确率为75%,AUC为0.78;添加PGS后这些指标没有实质性变化。PGS在欧洲血统组中是第10个最重要的预测因素,在非洲血统组中是第23个。在年龄分层分析中,在欧洲血统中,PGS在<40岁人群中排名第8,在≥40岁人群中排名第48;在非洲血统样本中,PGS在<40岁人群中排名第14,在≥40岁人群中排名第24。

结论

饮酒、精神问题和合并的躯体疾病是寻求治疗的预测因素。纳入PGS并没有实质性改变模型性能,但在年轻的AUD患者中是一个更重要的预测因素。

要点

虽然饮酒问题很常见,但很少有人寻求治疗我们在一个深度表型样本中使用机器学习来预测寻求治疗的情况我们首次将酒精使用的多基因风险作为预测因素饮酒变量、精神问题和躯体问题是关键预测因素。